Literature DB >> 12941085

Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Behçet's disease.

E Alpsoy1, S Uzun, A Akman, M Alpaslan Acar, H R Memişoglu, E Başaran.   

Abstract

BACKGROUND: Papulopustular lesions (PPL), the most common type of cutaneous lesions in Behçet's disease (BD), clinically may not be differentiated from ordinary acne. Disagreement exists as to the exact nature of these acneiform and folliculitis-like lesions and whether to include them as a major criterion.
OBJECTIVE: We investigated whether PPL can be a useful tool for the diagnosis of BD when non-follicular lesions over the trunk or extremities were selected, and were correlated with histological and/or immunofluorescence study.
METHODS: Seventeen patients with BD (five women, 12 men; mean +/- SEM age, 32 +/- 7.9 years), were enrolled in the study with blind histopathological and immunofluorescence studies. Biopsies of the PPL and adjacent (approximately 2 cm distant) normal-appearing skin were performed from the extremities and trunk. Follicle-based acneiform lesions and those lesions over face were excluded. Histological evaluation primarily included epidermal and dermal alterations, cellular infiltration and vascular changes. We also performed direct immunofluorescence studies, using polyclonal antibodies for IgA, IgG, IgM, C3 and fibrin.
RESULTS: Lesional specimens of the patients with BD revealed a significant leucocytoclastic vasculitis as compared with non-lesional skin (P<0.05). The vessels of the lesional skin showed a higher IgM deposition than non-lesional skin (52.9% and 17.6%) (P<0.05). IgG, C3 and fibrin deposits on the vessels of the lesional skin were also higher than non-lesional skin (35.3, 11.8%; 41.2, 17.6%; and 47.1, 17.6%, respectively), but the differences were not statistically significant.
CONCLUSIONS: Our findings indicate that non-follicular PPL over the trunk or extremities are more specific, and immune complex-mediated vasculitis is likely to be the main feature of these lesions, as they are in other cutaneous lesions of BD.

Entities:  

Mesh:

Year:  2003        PMID: 12941085     DOI: 10.1046/j.1468-3083.2003.00625.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

Review 1.  Mucocutaneous lesions of Behcet's disease.

Authors:  Erkan Alpsoy; Christos Constantin Zouboulis; George Edward Ehrlich
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

Review 2.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

3.  Histopathological Evaluation of Behçet's Disease and Identification of New Skin Lesions.

Authors:  Ozgür Gündüz
Journal:  Patholog Res Int       Date:  2011-10-18

4.  Clinical and Pathological Manifestations with Differential Diagnosis in Behçet's Disease.

Authors:  Aysin Kokturk
Journal:  Patholog Res Int       Date:  2011-11-28

5.  Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.

Authors:  Federica Delunardo; Fabrizio Conti; Paola Margutti; Cristiano Alessandri; Roberta Priori; Alessandra Siracusano; Rachele Riganò; Elisabetta Profumo; Guido Valesini; Maurizio Sorice; Elena Ortona
Journal:  Arthritis Res Ther       Date:  2006-04-12       Impact factor: 5.156

6.  Keratosis lichenoides chronica successfully treated with isotretinoin and methotrexate.

Authors:  Alvin W Li; William Damsky; Brett A King
Journal:  JAAD Case Rep       Date:  2017-04-14

7.  Direct immunofluorescence in Behçet's disease: a controlled study with 108 cases.

Authors:  Afet Akdag Kose
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.